Neurotoxic Mode of Action of Artemisinin
Open Access
- 1 March 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (3) , 821-827
- https://doi.org/10.1128/aac.46.3.821-827.2002
Abstract
We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell cultures (G. Schmuck and R. K. Haynes, Neurotoxicity Res. 2:37-49, 2000). Here, we probe possible mechanisms of this brain stem-specific neurodegeneration, in which artemisinin-sensitive neuronal brain stem cell cultures are compared with nonsensitive cultures (cortical neurons, astrocytes). Effects on the cytoskeleton of brain stem cell cultures, but not that of cortical cell cultures, were visible after 7 days. However, after a recovery period of 7 days, this effect also became visible in cortical cells and more severe in brain stem cell cultures. Neurodegeneration appears to be induced by effects on intracellular targets such as the cytoskeleton, modulation of the energy status by mitochondrial or metabolic defects, oxidative stress or excitotoxic events. Artemisinin reduces intracellular ATP levels and the potential of the inner mitochondrial membrane below the cytotoxic concentration range in all three cell cultures, with these effects being most dominant in the brain stem cultures. Surprisingly, there were substantial effects on cortical neurons after 7 days and on astrocytes after 1 day. Artemisinin additionally induces oxidative stress, as observed as an increase of reactive oxygen species and of lipid peroxidation in both neuronal cell types. Interestingly, an induction of expression of AOE was only seen in astrocytes. Here, manganese superoxide dismutase (MnSOD) expression was increased more than 3-fold and catalase expression was increased more than 1.5-fold. In brain stem neurons, MnSOD expression was dose dependently decreased. Copper-zinc superoxide dismutase and glutathione peroxidase, two other antioxidant enzymes that were investigated, did not show any changes in their mRNA expression in all three cell types after exposure to artemisinin.Keywords
This publication has 40 references indexed in Scilit:
- Ferryl–oxo heme intermediate in the antimalarial mode of action of artemisininFEBS Letters, 2000
- Influence of Tumor Necrosis Factor-α and Silibin on the Cytotoxic Action of α-Amanitin in Rat Hepatocyte CultureToxicology and Applied Pharmacology, 1999
- Cytoskeletal Breakdown and Apoptosis Elicited by NO Donors in Cerebellar Granule Cells Require NMDA Receptor ActivationJournal of Neurochemistry, 1996
- An in Vitro Model for Toxicological Investigations of Environmental Neurotoxins in Primary Neuronal Cell CulturesToxicology and Industrial Health, 1996
- CNS Adverse Events Associated With Antimalarial Agents Fact or Fiction?Drug Safety, 1995
- INVOLVEMENT OF CYTOSKELETAL PROTEINS IN THE MECHANISMS OF ORGANOPHOSPHORUS ESTER‐INDUCED DELAYED NEUROTOXICITYClinical and Experimental Pharmacology and Physiology, 1995
- Bioenergetic and oxidative stress in neurodegenerative diseasesLife Sciences, 1995
- Cloning and characterization of the rat glutathione peroxidase geneFEBS Letters, 1992
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985
- THE PROBLEMS OF NEURONS WITH LONG AXONSThe Lancet, 1984